Knocking off the suppressors of cytokine signaling (SOCS): their roles in mammalian pregnancy

Journal of Reproductive Immunology

Volumn 83, Issue 1-2, 2009, Pages 117-123

  Fitzgerald, Justine S ^a   Toth, Bettina ^b   Jeschke, Udo ^b   Schleussner, Ekkehard ^a   Markert, Udo R ^a  

^a Abteilung Geburtshilfe   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

IL 6; JAK STAT; Knockout mice; LIF; Pregnancy; SOCS

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 4; JANUS KINASE; LEUKEMIA INHIBITORY FACTOR; PROTEIN SH2; STAT PROTEIN; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING; SUPPRESSOR OF CYTOKINE SIGNALING 1; SUPPRESSOR OF CYTOKINE SIGNALING 2; SUPPRESSOR OF CYTOKINE SIGNALING 3; SUPPRESSOR OF CYTOKINE SIGNALING 4; SUPPRESSOR OF CYTOKINE SIGNALING 5; SUPPRESSOR OF CYTOKINE SIGNALING 6; SUPPRESSOR OF CYTOKINE SIGNALING 7; UNCLASSIFIED DRUG;

ABORTION; ARTICLE; CELLULAR IMMUNITY; EMBRYO DEVELOPMENT; EMBRYONIC STRUCTURES; FEMALE FERTILITY; GENE DELETION; GENE DISRUPTION; GENE TARGETING; GROWTH RETARDATION; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; IMMUNOSTIMULATION; MAMMAL; NONHUMAN; PHENOTYPE; PLACENTA INSUFFICIENCY; PREGNANCY; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; SIGNAL TRANSDUCTION; TH1 CELL; TH2 CELL; TROPHOBLAST;

ANIMALS; CELL DIFFERENTIATION; CYTOKINES; FEMALE; HUMANS; MICE; PLACENTATION; PREGNANCY; SIGNAL TRANSDUCTION; STAT TRANSCRIPTION FACTORS; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TH1 CELLS; TH2 CELLS; TROPHOBLASTS;

EID: 70449720528     PISSN: 01650378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jri.2009.07.010     Document Type: Article

References (56)

1. Alexander W.S., and Hilton D.J. The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response. Annu. Rev. Immunol. 22 (2004) 503-529
2. Alexander W.S., Starr R., Fenner J.E., Scott C.L., Handman E., Sprigg N.S., et al. SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine. Cell 98 5 (1999) 597-608
3. Antony P.A., and Restifo N.P. CD4+CD25+ T regulatory cells, immunotherapy of cancer, and interleukin-2. J. Immunother. 28 2 (2005) 120-128
4. Banks A.S., Li J., McKeag L., Hribal M.L., Kashiwada M., Accili D., et al. Deletion of SOCS7 leads to enhanced insulin action and enlarged islets of Langerhans. J. Clin. Invest. 115 9 (2005) 2462-2471
5. Blumenstein M., Bowen-Shauver J.M., Keelan J.A., and Mitchell M.D. Identification of suppressors of cytokine signaling (SOCS) proteins in human gestational tissues: differential regulation is associated with the onset of labor. J. Clin. Endocrinol. Metab. 87 3 (2002) 1094-1097
6. Boyle K., and Robb L. The role of SOCS3 in modulating leukaemia inhibitory factor signalling during murine placental development. J. Reprod. Immunol. 77 1 (2008) 1-6
7. Brender C., Columbus R., Metcalf D., Handman E., Starr R., Huntington N., et al. SOCS5 is expressed in primary B and T lymphoid cells but is dispensable for lymphocyte production and function. Mol. Cell Biol. 24 13 (2004) 6094-6103
8. Cacalano N.A., Sanden D., and Johnston J.A. Tyrosine-phosphorylated SOCS-3 inhibits STAT activation but binds to p120 RasGAP and activates Ras. Nat. Cell Biol. 3 5 (2001) 460-465
9. Caniggia I., Grisaru-Gravnosky S., Kuliszewsky M., Post M., and Lye S.J. Inhibition of TGF-beta 3 restores the invasive capability of extravillous trophoblasts in preeclamptic pregnancies. J. Clin. Invest. 103 12 (1999) 1641-1650
10. Carney E.W., Prideaux V., Lye S.J., and Rossant J. Progressive expression of trophoblast-specific genes during formation of mouse trophoblast giant cells in vitro. Mol. Reprod. Dev. 34 4 (1993) 357-368
11. Chaouat G., Assal Meliani A., Martal J., Raghupathy R., Elliott J.F., Mosmann T., et al. IL-10 prevents naturally occurring fetal loss in the CBA × DBA/2 mating combination, and local defect in IL-10 production in this abortion-prone combination is corrected by in vivo injection of IFN-tau. J. Immunol. 154 9 (1995) 4261-4268
12. Chaouat G., Ledee-Bataille N., Dubanchet S., Zourbas S., Sandra O., and Martal J. TH1/TH2 paradigm in pregnancy: paradigm lost? Cytokines in pregnancy/early abortion: reexamining the TH1/TH2 paradigm. Int. Arch. Allergy Immunol. 134 2 (2004) 93-119
13. Corvinus F.M., Fitzgerald J.S., Friedrich K., and Markert U.R. Evidence for a correlation between trophoblast invasiveness and STAT3 activity. Am. J. Reprod. Immunol. 50 4 (2003) 316-321
14. Croker B.A., Kiu H., and Nicholson S.E. SOCS regulation of the JAK/STAT signalling pathway. Semin. Cell Dev. Biol. 19 4 (2008) 414-422
15. Cross J.C. Genetic insights into trophoblast differentiation and placental morphogenesis. Semin. Cell Dev. Biol. 11 2 (2000) 105-113
16. Dong Q., Fan R., Zhao S., and Wang Y. Over-expression of SOCS-3 gene promotes IL-10 production by JEG-3 trophoblast cells. Placenta 30 1 (2009) 11-14
17. Fitzgerald J.S., Poehlmann T.G., Schleussner E., and Markert U.R. Trophoblast invasion: the role of intracellular cytokine signalling via signal transducer and activator of transcription 3 (STAT3). Hum. Reprod. Update 14 4 (2008) 335-344
18. Fitzgerald J.S., Tsareva S.A., Poehlmann T.G., Berod L., Meissner A., Corvinus F.M., et al. Leukemia inhibitory factor triggers activation of signal transducer and activator of transcription 3, proliferation, invasiveness, and altered protease expression in choriocarcinoma cells. Int. J. Biochem. Cell Biol. 37 11 (2005) 2284-2296
19. Fujimoto M., Naka T., Nakagawa R., Kawazoe Y., Morita Y., Tateishi A., et al. Defective thymocyte development and perturbed homeostasis of T cells in STAT-induced STAT inhibitor-1/suppressors of cytokine signaling-1 transgenic mice. J. Immunol. 165 4 (2000) 1799-1806
20. Fujimoto M., Tsutsui H., Yumikura-Futatsugi S., Ueda H., Xingshou O., Abe T., et al. A regulatory role for suppressor of cytokine signaling-1 in T(h) polarization in vivo. Int. Immunol. 14 11 (2002) 1343-1350
21. Greenhalgh C.J., Metcalf D., Thaus A.L., Corbin J.E., Uren R., Morgan P.O., et al. Biological evidence that SOCS-2 can act either as an enhancer or suppressor of growth hormone signaling. J. Biol. Chem. 277 43 (2002) 40181-40184
22. Haan S., Ferguson P., Sommer U., Hiremath M., McVicar D.W., Heinrich P.C., et al. Tyrosine phosphorylation disrupts elongin interaction and accelerates SOCS3 degradation. J. Biol. Chem. 278 34 (2003) 31972-31979
23. Hanna N., Hanna I., Hleb M., Wagner E., Dougherty J., Balkundi D., et al. Gestational age-dependent expression of IL-10 and its receptor in human placental tissues and isolated cytotrophoblasts. J. Immunol. 164 11 (2000) 5721-5728
24. Hilton D.J. Negative regulators of cytokine signal transduction. Cell. Mol. Life Sci. 55 12 (1999) 1568-1577
25. Horvat S., and Medrano J.F. Lack of Socs2 expression causes the high-growth phenotype in mice. Genomics 72 2 (2001) 209-212
26. Isobe A., Takeda T., Sakata M., Yamamoto T., Minekawa R., Hayashi M., et al. STAT3-mediated constitutive expression of SOCS3 in an undifferentiated rat trophoblast-like cell line. Placenta 27 8 (2006) 912-918
27. Jiang K., Chen Y., and Jarvis J.N. Soluble factors from LPS- and PHA-activated PBMC induce MAPK, Stat1 and Stat3 phosphorylation in primary cultures of human term placental trophoblasts: implications for infection and prematurity. Placenta 28 5-6 (2007) 538-542
28. Keelan J.A., Blumenstein M., Helliwell R.J., Sato T.A., Marvin K.W., and Mitchell M.D. Cytokines, prostaglandins and parturition-a review. Placenta 24 Suppl. A (2003) S33-46
29. Kile B.T., Schulman B.A., Alexander W.S., Nicola N.A., Martin H.M., and Hilton D.J. The SOCS box: a tale of destruction and degradation. Trends Biochem. Sci. 27 5 (2002) 235-241
30. Kinjyo I., Inoue H., Hamano S., Fukuyama S., Yoshimura T., Koga K., et al. Loss of SOCS3 in T helper cells resulted in reduced immune responses and hyperproduction of interleukin 10 and transforming growth factor-beta 1. J. Exp. Med. 203 4 (2006) 1021-1031
31. Kopchick J.J., Bellush L.L., and Coschigano K.T. Transgenic models of growth hormone action. Annu. Rev. Nutr. 19 (1999) 437-461
32. Krebs D.L., Metcalf D., Merson T.D., Voss A.K., Thomas T., Zhang J.G., et al. Development of hydrocephalus in mice lacking SOCS7. Proc. Natl. Acad. Sci. U.S.A. 101 43 (2004) 15446-15451
33. Krebs D.L., Uren R.T., Metcalf D., Rakar S., Zhang J.G., Starr R., et al. SOCS-6 binds to insulin receptor substrate 4, and mice lacking the SOCS-6 gene exhibit mild growth retardation. Mol. Cell. Biol. 22 13 (2002) 4567-4578
34. Larsen L., and Ropke C. Suppressors of cytokine signalling: SOCS. APMIS 110 12 (2002) 833-844
35. Li S., Chen S., Xu X., Sundstedt A., Paulsson K.M., Anderson P., et al. Cytokine-induced Src homology 2 protein (CIS) promotes T cell receptor-mediated proliferation and prolongs survival of activated T cells. J. Exp. Med. 191 6 (2000) 985-994
36. Lockwood C.J., Yen C.F., Basar M., Kayisli U.A., Martel M., Buhimschi I., et al. Preeclampsia-related inflammatory cytokines regulate interleukin-6 expression in human decidual cells. Am. J. Pathol. 172 6 (2008) 1571-1579
37. Marine J.C., McKay C., Wang D., Topham D.J., Parganas E., Nakajima H., et al. SOCS3 is essential in the regulation of fetal liver erythropoiesis. Cell 98 5 (1999) 617-627
38. Marine J.C., Topham D.J., McKay C., Wang D., Parganas E., Stravopodis D., et al. SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality. Cell 98 5 (1999) 609-616
39. Matsumoto A., Seki Y., Kubo M., Ohtsuka S., Suzuki A., Hayashi I., et al. Suppression of STAT5 functions in liver, mammary glands, and T cells in cytokine-inducible SH2-containing protein 1 transgenic mice. Mol. Cell. Biol. 19 9 (1999) 6396-6407
40. Metcalf D., Greenhalgh C.J., Viney E., Willson T.A., Starr R., Nicola N.A., et al. Gigantism in mice lacking suppressor of cytokine signalling-2. Nature 405 6790 (2000) 1069-1073
41. Naka T., Matsumoto T., Narazaki M., Fujimoto M., Morita Y., Ohsawa Y., et al. Accelerated apoptosis of lymphocytes by augmented induction of Bax in SSI-1 (STAT-induced STAT inhibitor-1) deficient mice. Proc. Natl. Acad. Sci. U.S.A. 95 26 (1998) 15577-15582
42. Naka T., Tsutsui H., Fujimoto M., Kawazoe Y., Kohzaki H., Morita Y., et al. SOCS-1/SSI-1-deficient NKT cells participate in severe hepatitis through dysregulated cross-talk inhibition of IFN-gamma and IL-4 signaling in vivo. Immunity 14 5 (2001) 535-545
43. Poehlmann T.G., Fitzgerald J.S., Meissner A., Wengenmayer T., Schleussner E., Friedrich K., et al. Trophoblast invasion: tuning through LIF, signalling via Stat3. Placenta 26 Suppl. A (2005) S37-41
44. Redline R.W., and Patterson P. Pre-eclampsia is associated with an excess of proliferative immature intermediate trophoblast. Hum. Pathol. 26 6 (1995) 594-600
45. Rein D.T., Breidenbach M., Honscheid B., Friebe-Hoffmann U., Engel H., Gohring U.J., et al. Preeclamptic women are deficient of interleukin-10 as assessed by cytokine release of trophoblast cells in vitro. Cytokine 23 4-5 (2003) 119-125
46. Robb L., Boyle K., Rakar S., Hartley L., Lochland J., Roberts A.W., et al. Genetic reduction of embryonic leukemia-inhibitory factor production rescues placentation in SOCS3-null embryos but does not prevent inflammatory disease. Proc. Natl. Acad. Sci. U.S.A. 102 45 (2005) 16333-16338
47. Rossant J., and Cross J.C. Placental development: lessons from mouse mutants. Nat. Rev. Genet. 2 7 (2001) 538-548
48. Scheffold A., Huhn J., and Hofer T. Regulation of CD4+CD25+ regulatory T cell activity: it takes (IL-)two to tango. Eur. J. Immunol. 35 5 (2005) 1336-1341
49. Seki Y., Hayashi K., Matsumoto A., Seki N., Tsukada J., Ransom J., et al. Expression of the suppressor of cytokine signaling-5 (SOCS5) negatively regulates IL-4-dependent STAT6 activation and Th2 differentiation. Proc. Natl. Acad. Sci. U.S.A. 99 20 (2002) 13003-13008
50. Seki Y., Inoue H., Nagata N., Hayashi K., Fukuyama S., Matsumoto K., et al. SOCS-3 regulates onset and maintenance of T(H)2-mediated allergic responses. Nat. Med. 9 8 (2003) 1047-1054
51. Takahashi Y., Carpino N., Cross J.C., Torres M., Parganas E., and Ihle J.N. SOCS3: an essential regulator of LIF receptor signaling in trophoblast giant cell differentiation. EMBO J. 22 3 (2003) 372-384
52. Takahashi Y., Takahashi M., Carpino N., Jou S.T., Chao J.R., Tanaka S., et al. Leukemia inhibitory factor regulates trophoblast giant cell differentiation via Janus kinase 1-signal transducer and activator of transcription 3-suppressor of cytokine signaling 3 pathway. Mol. Endocrinol. 22 7 (2008) 1673-1681
53. Takeda K., Noguchi K., Shi W., Tanaka T., Matsumoto M., Yoshida N., et al. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc. Natl. Acad. Sci. U.S.A. 94 8 (1997) 3801-3804
54. Teglund S., McKay C., Schuetz E., van Deursen J.M., Stravopodis D., Wang D., et al. Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell 93 5 (1998) 841-850
55. Udy G.B., Towers R.P., Snell R.G., Wilkins R.J., Park S.H., Ram P.A., et al. Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc. Natl. Acad. Sci. U.S.A. 94 14 (1997) 7239-7244
56. Zhao S., Gu Y., Dong Q., Fan R., and Wang Y. Altered interleukin-6 receptor, IL-6R and gp130, production and expression and decreased SOCS-3 expression in placentas from women with pre-eclampsia. Placenta 29 12 (2008) 1024-1028